LexDanaLexDanabeta
Inventor

NABIL KERROUCHE

Inventor
FR

Overview

2→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07KPeptides20%
PatentTitleYear
12,435,147Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation202511,213,539Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to Galderma Holding SA (2)· patent assignee history
2022–2025Based in FR· patent location history
2025Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
Galderma Holding SA22022–2025
CHUGAI PHARMACEUTICAL CO LTD12025
Locations
LocationPatentsSpan
FR22022–2025